Effects of pyrazinamide, probenecid, and benzbromarone on renal excretion of oxypurinol.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 1929586.
- Also identified by PMC identifier 1004507.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The effects of pyrazinamide, probenecid, and benzbromarone on renal excretion of oxypurinol were investigated. Pyrazinamide decreased the mean (SEM) fractional clearance of oxypurinol from 19.2 (2.1) to 8.8 (1.5). Probenecid increased the fractional clearance of oxypurinol from 14.1 (3.5) to 24.8 (4.1). Benzbromarone increased the fractional clearance of oxypurinol from 15.6 (2.3) to 33.8 (2.8). These results suggest that oxypurinol may be secreted by 'an organic acid system' and that oxypurinol is reabsorbed at a putative postsecretory site of the renal tubules.
Medical subject headings
- Benzbromarone
- Kidney
- Oxypurinol
- Probenecid
- Pyrazinamide